GlassScriptPhysician profile
Chitra Ramasubbu
NPI 1467614016
$5,754.62
in general payments reported to CMS, 2019-2025
29 companies · $3,215 in 2025
The $3,215 reported for 2025 was more than what 89% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $611 · 2020: $430 · 2021: $249 · 2022: $467 · 2023: $364 · 2024: $419 · 2025: $3,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,602 · Travel and Lodging: $1,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,601.72 |
| Travel and Lodging | $1,396.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,241.90 | 2022-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Boston Scientific Corporation | $784.87 | 2021-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Abbvie INC. | $553.64 | 2022-2025 | |
| Allergan, INC. | $347.08 | 2019-2022 | |
| Spr Therapeutics, INC | $308.12 | 2019-2025 | Sprint Pns System |
| Curonix LLC | $215.19 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Mdd US Operations, LLC | $203.54 | 2019-2021 | |
| Pfizer INC. | $111.74 | 2019-2021 | |
| Merz Pharmaceuticals, LLC | $104.21 | 2023-2025 | Xeomin |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $102.17 | 2019-2020 | |
| Si-Bone, INC. | $87.69 | 2025 | |
| Medtronic USA, INC. | $84.46 | 2019 | |
| Lundbeck LLC | $75.83 | 2024-2025 | Vyepti |
| Averitas Pharma INC. | $71.99 | 2024-2025 | Qutenza |
| Nevro Corp. | $49.87 | 2022-2023 | Senza |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $46.25 | 2024-2025 | Proclaim, Eterna |
| Globus Medical, INC. | $41.39 | 2025 | Senza |
| Tersera Therapeutics LLC | $39.62 | 2019 | |
| Novartis Pharmaceuticals Corporation | $38.31 | 2019-2020 | |
| Daiichi Sankyo INC. | $37.14 | 2019 | |
| Lilly USA, LLC | $36.29 | 2021 | |
| Biotronik Nro, INC. | $34.30 | 2025 | Prospera |
| Avanos Medical | $26.67 | 2024 | Standard Rf Disposables |
| Fidia Pharma USA INC. | $24.00 | 2025 | Hymovis, Triluron |
| Organogenesis INC. | $21.57 | 2025 | Puraply Wound Matrix |
| Arbor Pharmaceuticals, INC. | $20.52 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $20.17 | 2022 | |
| Collegium Pharmaceutical, INC. | $14.95 | 2024 | Xtampza |
| Redhill Biopharma INC. | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chitra Ramasubbu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.